EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection

Daniel Centeno, Sadaf Farsinejad, Elena Kochetkova, Tatiana Volpari, Aleksandra Gladych-Macioszek iD, Agnieszka Klupczynska-Gabryszak iD, Teagan Polotaye, Michael Greenberg, Douglas Kung, Emily Hyde iD, Sarah Alshehri iD, Tonja Pavlovic und 11 weitere

Nutrients · 2024

DOI: 10.3390/nu16121816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Daniel Centeno und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA. Hauptthemen laut MEDLINE: Taurine, TOR Serine-Threonine Kinases, Ovarian Neoplasms, DNA Damage. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NCI, Stiftelsen Lars Hiertas Minne, The Swedish Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taurine, a non-proteogenic amino acid and commonly used nutritional supplement, can protect various tissues from degeneration associated with the action of the DNA-damaging chemotherapeutic agent cisplatin. Whether and how taurine protects human ovarian cancer (OC) cells from DNA damage caused by cisplatin is not well understood. We found that OC ascites-derived cells contained significantly more intracellular taurine than cell culture-modeled OC. In culture, elevation of intracellular taurine concentration to OC ascites-cell-associated levels suppressed proliferation of various OC cell lines and patient-derived organoids, reduced glycolysis, and induced cell protection from cisplatin. Taurine cell protection was associated with decreased DNA damage in response to cisplatin. A combination of RNA sequencing, reverse-phase protein arrays, live-cell microscopy, flow cytometry, and biochemical validation experiments provided evidence for taurine-mediated induction of mutant or wild-type p53 binding to DNA, activation of p53 effectors involved in negative regulation of the cell cycle (p21), and glycolysis (TIGAR). Paradoxically, taurine’s suppression of cell proliferation was associated with activation of pro-mitogenic signal transduction including ERK, mTOR, and increased mRNA expression of major DNA damage-sensing molecules such as DNAPK, ATM and ATR. While inhibition of ERK or p53 did not interfere with taurine’s ability to protect cells from cisplatin, suppression of mTOR with Torin2, a clinically relevant inhibitor that also targets DNAPK and ATM/ATR, broke taurine’s cell protection. Our studies implicate that elevation of intracellular taurine could suppress cell growth and metabolism, and activate cell protective mechanisms involving mTOR and DNA damage-sensing signal transduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TaurineTOR Serine-Threonine KinasesOvarian NeoplasmsDNA DamageCisplatinTumor Suppressor Protein p53HumansFemaleCell Line, TumorCell ProliferationSignal TransductionGlycolysisExtracellular Signal-Regulated MAP KinasesAntineoplastic Agents

Stichwörter der Autor:innen

cell protectionfallopian tube cellsgenotoxic stressgrowth suppressionovarian cancer cellssignal transductiontaurine

Substanzen

TaurineTOR Serine-Threonine KinasesCisplatinTumor Suppressor Protein p53MTOR protein, humanExtracellular Signal-Regulated MAP KinasesAntineoplastic AgentsTP53 protein, human

Autor:innen und Institutionen

  • Department of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA.
  • Department of Physiology and Pharmacology, Karolinska Institute, 171 77 Stockholm, Sweden.
  • The New York Stem Cell Foundation Research Institute, New York, NY 10019, USA.
  • Department of Reproduction, University Gynaecology and Obstetrics Hospital, 60-502 Poznań, Poland.
  • Department of Inorganic and Analytical Chemistry, Poznań University of Medical Sciences, 61-701 Poznań, Poland.
  • Department of Biosciences, Durham University, Durham DH1 3LE, UK.

ORCID-Profile: Aleksandra Gladych-Macioszek, Agnieszka Klupczynska-Gabryszak, Emily Hyde, Sarah Alshehri, Szymon Plewa, Frederick J Monsma, Jan Matysiak, Mikołaj Piotr Zaborowski, Laura A Martin, Marcin Iwanicki

Förderung

  • NIH/NCI
  • Stiftelsen Lars Hiertas Minne
  • The Swedish Cancer Society
  • NCI NIH HHS
  • Stiftelsen Sigurd & Elsa Goljes Minne
  • Stiftelsen Längmanska kulturfonden
  • Kaleidoscope of Hope Ovarian Cancer Research Foundation
  • The Swedish Research Council

Zitieren

APA

Centeno, D., Farsinejad, S., Kochetkova, E., Volpari, T., Gladych-Macioszek, A., Klupczynska-Gabryszak, A., Polotaye, T., Greenberg, M., Kung, D., Hyde, E., Alshehri, S., Pavlovic, T., Sullivan, W., Plewa, S., Vakifahmetoglu-Norberg, H., Monsma, F. J., Muller, P. A. J., Matysiak, J., Zaborowski, M. P., …, & Iwanicki, M. (2024). Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection. Nutrients. https://doi.org/10.3390/nu16121816

Vancouver

Centeno D, Farsinejad S, Kochetkova E, Volpari T, Gladych-Macioszek A, Klupczynska-Gabryszak A, et al. Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection. Nutrients. 2024. doi:10.3390/nu16121816

BibTeX
@article{Centeno2024,
  author = {Centeno, Daniel and Farsinejad, Sadaf and Kochetkova, Elena and Volpari, Tatiana and Gladych-Macioszek, Aleksandra and Klupczynska-Gabryszak, Agnieszka and Polotaye, Teagan and Greenberg, Michael and Kung, Douglas and Hyde, Emily and Alshehri, Sarah and Pavlovic, Tonja and Sullivan, William and Plewa, Szymon and Vakifahmetoglu-Norberg, Helin and Monsma, Frederick J and Muller, Patricia A J and Matysiak, Jan and Zaborowski, Mikołaj Piotr and DiFeo, Analisa and Norberg, Erik and Martin, Laura A and Iwanicki, Marcin},
  title = {Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16121816}
}
Kostenlos starten →